Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
BDBiodexa Pharmaceuticals Plc logo

Biodexa Pharmaceuticals Plc (BDRX)

NASDAQ Capital Market · Currency in USD
$0.42 ▲ +0.01 (+2.25%)
At close: Oct 23, 4:00 PM ET. Market closed.
$0.43 ▲ +0.01 (+1.18%)
After hours: Oct 23, 7:49 PM ET

Summary

Previous Close
$0.41
Open
$0.38
Day's Range
$0.38 – $0.43
52 Week Range
$0.34 – $357.60
Volume
230,831
Avg. Volume
3,550,529
Market Cap
$315.83K
Beta (5Y Monthly)
1.28
PE Ratio (TTM)
--
EPS (TTM)
-$297.48
Earnings Date
Apr 23, 2027
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Biodexa Pharmaceuticals Plc

Sector
Healthcare
Industry
Biotechnology
Full-time employees
11
CEO
Stephen Anthony Stamp

Biodexa Pharmaceuticals Plc, a biopharmaceutical company in the clinical development stage, is dedicated to advancing a diverse portfolio of products. Founded in 2000 and headquartered in Cardiff, United Kingdom, the company was formerly known as Midatech Pharma plc until its rebranding in March 2023. Its research and development efforts are focused on addressing significant unmet medical needs, including familial adenomatous polyposis, non-muscle invasive bladder cancer, Type 1 diabetes, and a spectrum of rare or orphan brain cancers.

Earnings

Next report: Fri, Apr 23, 2027
DateEst.Actual
Mar 27, 2026-$0.01-$0.00Beat
Sep 12, 2025-$0.02-$0.00Beat
Apr 11, 2025-$0.03-$0.03Miss
Sep 26, 2024-$1.12-$1.67Miss
Apr 19, 2024-$17.71-$17.72Miss
Sep 15, 2023–-$1,404.25

Get free alerts on BDRX and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.